triumph-1 trial retatrutide results: Retatrutide, the triple agonist. Significant weight loss ( 28.3% average loss at 80 weeks). It has potential to transform obesity treatment with results comparable to… Retatrutide TRIUMPH-1: Biggest Obesity Trial

[MUSIC PLAYING] KWONG: This episode was produced by Rachel Carlson and edited by Brent Baughman

Prescription GLP-1 drugs (Ozempic, Wegovy, Mounjaro) are a separate category entirely and require medical supervision

At MediPlan Diet Services , we offer doctor-guided weight loss support in Memphis , which may include GLP-1-based therapies or other prescription tools depending on your unique health profile

Medicare coverage limitations significantly impact usage patterns, with only 1% of adults over 65 using GLP-1 medications for weight loss compared to higher rates in younger populations ^19

These medications can help some patients feel full sooner, reduce food noise, improve portion control, support blood sugar regulation, and lose meaningful weight when used with medical supervision